Introduction
For a long time, epilepsy was considered to be a disorder of the central nervous system manifested only by the occurrence epileptic seizures and its treatment was focused in the achievement of a seizure-free state. In the last two decades, however, neurologists have concluded that seizures are only one of the clinical manifestations of a seizure disorder, as cognitive and psychiatric comorbidities have been identified in one of out every three patients with epilepsy (PWE) [1] . In fact, the new proposed definition of epilepsy proposed by a task force of the International League against Epilepsy (ILAE) reflects this fact: "Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures, and by the neurobiologic, cognitive, psychological, and social consequences of this condition" [2] . This definition implies a need to factor-in the existence of comorbid "psychiatric" conditions (referred in the definition as "psychological") in the comprehensive management of PWE, with mood and anxiety disorders accounting for the majority of these comorbidities [1] .
This definition implies that psychiatric comorbidities are a "consequence" of the seizure disorder. Yet, psychiatric comorbidities and epilepsy have a much more complex relation, as not only are PWE at increased risk of developing psychiatric disorders, but patients with a primary psychiatric disorder have an increased risk of developing epilepsy. Indeed, data from epidemiologic studies have suggested the existence of a "bidirectional" relation between several psychiatric disorders and epilepsy, including mood and anxiety disorders, attention deficit hyperactivity disorder (ADHD) and psychosis [3] [4] [5] [6] [7] [8] . This relation does not imply that epilepsy causes psychiatric disorders, or vice-versa, but rather, such relation could be explained by the existence of common pathogenic mechanisms operant in both epilepsy and the psychiatric disorders [9, 10] . Clearly, psychiatric disorders often precede the onset of the seizure disorder and they can have a very negative impact on the course and the treatment of a future seizure disorder, lest they be identified and treated in a timely manner. This article addresses this question.
Why should psychiatric comorbidities be identified in the initial evaluation of patients with new-onset epilepsy?
Psychiatric comorbidities can affect the course and the management of the seizure disorder at various levels. These include:
1) A history of mood disorders preceding the onset of epilepsy appears to be associated with an increased risk of treatmentresistant epilepsy [11, 12] . 2) A personal and/or a family psychiatric history have been associated with an increased risk of non-psychiatric and psychiatric adverse events (AEs) to AEDs [13] [14] [15] . 3) A current and/or past history of mood and anxiety disorders may facilitate the development of seizures associated with stressful situations [16, 17] .
Likewise, a lifetime psychiatric history preceding the onset of epilepsy can impact the life of PWE in the following areas: 1) A current mood and anxiety disorder is a strong predictor of poor quality of life [18] [19] [20] . 2) A current mood disorder is associated with an increased use of medical services leading to higher economic burdens for the patient, family and society as a hole [20] . 3) Comorbid psychiatric disorders, and in particular mood disorders and substance abuse, are associated with an increased risk of premature-death by external causes (e.g., accidents, suicide) [21, 22] .
We will discuss these points in greater detail below.
A. Impact of psychiatric history on the course and management of the seizure disorder.
A.1 A history of mood disorders preceding the onset of epilepsy appears to be associated with an increased risk of treatment-resistant epilepsy.
As stated above, data from several epidemiologic studies have suggested that psychiatric disorders can increase the risk of developing epileptic seizures [3] [4] [5] [6] [7] [8] . Furthermore, data from two studies appear to suggest the possibility that psychiatric illness preceding the onset of epilepsy may be associated with a worse response to pharmacotherapy with AEDs [11, 12] . For example, in one study of 780 consecutive patients with new onset epilepsy followed over a 20-month period, those with a psychiatric history preceding the onset of epilepsy were two-fold more likely to develop treatment resistant epilepsy than those without [11] . Depression accounted for the majority of this effect. In another study of 138 consecutive patients with new onset epilepsy, those who endorsed symptoms of depression and anxiety before the start of antiepileptic therapy were significantly less likely to be seizure free after 12 months of therapy [12] . Several hypotheses have been postulated to explain this phenomenon, including: (i) poor antiepileptic drug (AED) compliance associated with the psychiatric disorder [23] ; (ii) common pathogenic mechanisms operant in epilepsy and psychiatric disorders that facilitate a state of cortical hyperexcitability and hence a worse response to pharmacotherapy [9, 10] , some of which include higher glutamatergic and lower GABAergic cortical concentrations and increased cytokines such as 1b interleukin (among others). Clearly, the data presented above need to be replicated in larger prospective studies. Nonetheless, clinicians may need to weigh-in the potentially higher risk of a worse response to treatment in PWE who have a history of comorbid psychiatric comorbidities in their decision to discontinue AED.
Furthermore, stress is a very common trigger of seizures in PWE, which can be facilitated by a history of past and/or current mood and anxiety disorders [17, 18] . Accordingly, an early recognition and treatment of these common comorbid psychiatric disorders and providing PWE with appropriate strategies to cope with stress can have a direct bearing on minimizing the occurrence of seizures.
A.2 The role of psychiatric history on the choice of pharmacotherapy of the seizure disorder?
There are enough data to suggest that a past and/or current psychiatric history as well as a family psychiatric history should be factored-in the choice of AEDs. For example, a past history (and/or family psychiatric history of mood disorders) has been associated with a risk to develop depression when treated with several AEDs, including barbiturates, topiramate, and levetiracetam [12] [13] [14] . By the same token, patients with a past history of mood and/or anxiety disorders may benefit from trials with AEDs that have mood-stabilizing (e.g., carbamazepine, oxcarbazepine, lamotrigine, valproic acid) and/or anxiolytic (e.g., gabapentin, pregabalin) properties. Furthermore, discontinuation of these AEDs in PWE who have a past history these psychiatric comorbidities could increase the risk of their recurrence, particularly if these AEDs had played a therapeutic role in their remission [24] .
The impact of psychiatric comorbidities on the development of adverse events to AEDs has not been limited to psychiatric iatrogenic symptoms but include neurologic and systemic symptoms. For example, in a study of 188 consecutive PWE from five outpatient epilepsy clinics, all of whom underwent structured interviews to identify current and past Axis I psychiatric diagnoses according to DSM-IV criteria, investigators examined the presence and severity of AEs, measured with the Adverse Event Profile (AEP) [25, 26] . Compared to asymptomatic patients (n = 103), the AEP scores of patients with current mood and/or anxiety disorders were significantly higher, suggesting more severe AEs to AEDs. These findings persisted after eliminating any psychiatric adverse event from the AEP [26] . Similar findings were reported by other investigators [27] .
Furthermore, the increased risk of iatrogenic complications identified in PWE with a history of psychiatric comorbidities is not limited to pharmacotherapy with AEDs, but has been associated with epilepsy surgery. Indeed, patients with treatment-resistant focal epilepsy of temporal lobe origin who are being considered for an antero-temporal lobectomy are at a significant increased risk of experiencing post-surgical recurrence of depression and anxiety if they had a pre-surgical lifetime history of mood disorders [28] [29] [30] , while those with a presurgical history of personality disorder are at increased risk of severe post-surgical psychiatric complications, including psychotic episodes [31] . Clearly, these data illustrate how factoring-in the existence and the type of a comorbid psychiatric history can anticipate the risk of iatrogenic psychiatric adverse events and minimize their occurrence.
B. The impact of psychiatric history on the life of PWE: B.1 Early identification of personal and family psychiatric history can help anticipate the risk of recurrence of psychiatric comorbidities.
Most of the common psychiatric comorbidities that affect PWE can recur throughout the course of their life. For example, the severity of ADHD may lessen in adolescence but several debilitating symptoms (e.g., inattentiveness, poor frustration tolerance and impulsive behavior) persist into adulthood in 50 to 75% of patients [32] . Likewise, a first primary major depressive episode is associated with a 50% risk of a second episode, two with a 70% risk and three or more have a >90% risk of recurrence, while a history of primary school phobia in children has been associated with an increased risk of panic disorders in adults. Psychiatric episodes that recur after the onset of the seizure disorder may be clinically indistinguishable from those preceding it, although denovo atypical manifestations can develop, in particular, mood disorders [33] .
Of greater concern is the higher suicidal risk that PWE have relative to the general population. As demonstrated in a Danish population-based study, a comorbid mood disorders increases the suicidal risk by 42-fold, while anxiety and psychotic disorders increase the risk by 12 fold [21] . In that study, suicides occurred more frequently during the first six months after the diagnosis of epilepsy; this finding underscores the need to identify PWE that are at risk of suicide from the time of the first evaluation.
Furthermore, premature mortality is a well-known phenomenon in PWE, as illustrated in a Swedish population study that demonstrated that premature mortality was 11-fold more frequent among PWE than among the general population and unaffected siblings [22] . Furthermore, a lifetime prevalence of psychiatric disorders was 40.7% (compared with 10.3% in controls). Among all deaths, 15.8% were attributed to external causes, which included death by suicide, and accidents (in a motor vehicle or through drug poisoning, falls, drowning, assault and other incidents). Of note, 75% of PWE who died from external causes were found to suffer from one or more psychiatric comorbidities, mainly depression and drug misuse.
B.2 The impact of psychiatric comorbidities on the quality of life of PWE:
Intuitively, achieving a seizure-free state should be expected to improve the quality of life of PWE. After all, the common obstacles that commonly interfere with their daily activities (e.g., driving) are lifted following a seizure-free period. Yet, psychiatric comorbidities have a direct bearing on their quality of life and often are independent predictors of poor health measures [18] [19] [20] 34] be the strongest independent predictors of poor quality of life. These data were derived from studies in which psychopathology was identified with screening instruments that identified in particular symptoms of depression and anxiety. One study that relied on the use of a structured interview to identify Axis I psychiatric diagnosis, according to the DSM-IV-TR criteria reached similar conclusions. In that study of 188 consecutive PWE from five outpatient clinics, half-of whom were seizure-free, 88 patients were found to have a mood and/or anxiety disorder [34] . The poor quality of life was not only limited to patients with major depressive episodes and/or a clearly established anxiety disorder, but also included patients with sub-syndromic forms of depressive episodes.
C. Identifying common psychiatric comorbidities in the outpatient clinic:
Based on the data reviewed above, the evaluation of any patient with newly diagnosed epilepsy should include at the minimum an investigation of the following psychiatric comorbidities: 1 Lifetime and current psychiatric history of mood, anxiety, attention deficit disorders and psychotic disorders. 2 A family psychiatric history of these disorders, since a genetic predisposition is a pivotal factor in the development of mood, anxiety and attention deficit disorders. 3 An assessment of the patient's and family members understanding of the diagnosis of epilepsy, their fears and concerns and whether they are having a problem accepting that the patient suffers from epilepsy. This is a pivotal aspect of any evaluation, which, unfortunately is rarely investigated and which when not properly addressed can have a long-term negative impact on the overall management of the seizure disorder and the quality of life of the patient and family members alike.
Investigation of psychiatric comorbidities in a busy epilepsy outpatient clinic can be difficult to achieve, given time constraints of allotted time to patients' visit. The use of self-rating screening instruments has been implemented to begin identifying patients experiencing symptoms of the two most common psychiatric comorbidities, depression and anxiety disorders. Most of the screening instruments were developed for the screening of symptoms in patients with primary psychiatric disorders and not in patients with epilepsy, with the exception of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), which was developed to screen for a possible diagnosis of Major Depressive Episode [35] . In addition, two self-rating screening instruments for the identification of symptoms of depression, the Beck Depression Inventory-II (BDI-II) and the Center for Epidemiologic StudiesDepression Scale (CES-D) have been recently validated in patients with epilepsy [36] , while the Generalized Anxiety Disorder-7 has been frequently used by clinicians to identify symptoms of anxiety disorders in general practice [37] . To screen for ADHD in children with epilepsy, clinicans have used the Connors' Parent/Teacher Rating Scales, which identifies behavior problems through parent and teacher report and particularly symptoms of ADHD in children ranging in age from 3 to 17 years [38] .
Yet, these instruments are designed to identify current symptoms that have been present for the previous two to four weeks and do not a prior history of these symptoms. Furthermore, these instruments only suggest the possibility of a psychiatric condition, but are not set-up to establish a categorical diagnosis of the psychiatric condition, let alone the diagnosis of psychiatric entities with atypical manifestations encountered in patients with epilepsy.
Accordingly, clinicians have to follow-up their evaluation with either an open set of questions, or a semi-structured or structured interview designed to establish a diagnosis of a current and past psychiatric disorder. The MINI Neuropsychiatric International Neuropsychiatric Interview (MINI) is a short structured interview that can be administered over a 20-minute period by nurses and/or social workers and can provide an acceptable evaluation [39] . Furthermore, the Family History Screen for Epidemiologic Studies (FHE) is a user-friendly screening instrument that can be used in research [40] . It should be stressed, however, that a psychiatric evaluation should not be limited to PWE that score in the symptomatic range in self-rating instruments.
Concluding remarks
The data reviewed in this article highlight the negative impact that a psychiatric history commonly identified in patients with newly diagnosed epilepsy can have on the course and management of their seizure disorder, as well as on the risk of their recurrence as psychiatric comorbidities and/or iatrogenic complications. Accordingly, investigation of any personal and/or family psychiatric history should be part of any initial evaluation, as it may play a significant role on the choice of AED. In fact, recognition of such history at the time of the initial evaluation is equivalent to the identification of hypertension, diabetes and tabaquism in patients with a newly diagnosed cerebrovascular accident. Yet, while failure to document such history in stroke patients would be considered unacceptable, failure to obtain a psychiatric history in patients with newly diagnosed epilepsy tends to be the rule, rather the exception.
While the need to recognize and incorporate a psychiatric history into a comprehensive treatment plan of PWE is being predicated in multiple publications, it has yet to be implemented in the daily clinical practice. Of greater concern, medical students, residents and fellows are not taught and are rarely expected to include an investigation of the patient's current and past psychiatric history when they take a clinical history in the outpatient and inpatient settings. Until these omissions are eliminated from our clinical practice, the evaluation of patients with new onset epilepsy will remain incomplete and fraught with the potential risks of significant spontaneous and iatrogenic psychiatric symptomatology that can have dire consequences not only in these patients' quality of life, but on the management of the seizure disorder.
